LA SETA CATAMANCIO, SIMONA

LA SETA CATAMANCIO, SIMONA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215 1-gen-2000 S. RusconiS. La Seta Catamancio + Article (author) -
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects 1-feb-2002 S. RusconiE. BulgheroniS. La Seta-CatamancioF.G. CroceM. Lo CiceroP.M. CitterioM. Galli Article (author) -
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation 1-lug-1999 S. RusconiS. La Seta-CatamancioM. GalazziD. TrabattoniM. GalliM. Clerici + Article (author) -
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection : in vitro studies of mixed virus infections 1-ott-2000 S. RusconiS. La Seta CatamancioP. CitterioE. BulgheroniF. CroceM. Galli + Article (author) -
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES 18-giu-1999 S. RusconiS. La Seta-CatamancioP.M. Citterio + Article (author) -
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine 1-set-1999 S. RusconiS. La Seta-CatamancioP.M. CitterioA. d'Arminio-MonforteM. GalliM. Moroni + Article (author) -
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure 1-mar-2001 S. La Seta-CatamancioP. CitterioM. GalliS. Rusconi + Article (author) -
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs 1-set-2000 S. RusconiS. La Seta CatamancioP. CitterioE. BulgheroniF. CroceM. Galli + Article (author) -
In vitro inhibition of HIV-1 by Met-SDF-1β alone or in combination with antiretroviral drugs 1-gen-2000 Rusconi S.La Seta Catamancio S.Citterio P.Bulgheroni E.Croce F.Galli M. + Article (author) -
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure 1-gen-1998 S. RusconiE. BulgheroniP.M. CitterioS. La Seta-CatamancioM. Galli + Article (author) -
Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine 1-nov-1998 S. RusconiS. La Seta-CatamancioP. CitterioA. d'Arminio-MonforteM. GalliM. Moroni + Article (author) -
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase 1-gen-2000 S. La Seta-CatamancioM. ViolinC. BalottaS. Rusconi + Article (author) -
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors 1-mag-2000 S. RusconiS. La Seta CatamancioP. CitterioM. ViolinC. BalottaM. MoroniM. GalliA. d'Arminio Monforte + Article (author) -
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine 1-mar-2001 S. RusconiLA SETA CATAMANCIO, SIMONAP. CitterioBULGHERONI, ELISABETTAM. GalazziCROCE, FRANCESCO GIULIOM. MoroniM. Galli + Article (author) -